Synthetic Solutions:Nabilone and the Group C Release of Delta-9 THC
The federal government never intended for delta-9 THC to be released as a medicine, but in the late 1970s, the medical marijuana movement placed immense pressure on drug agencies to help cancer patients who were suffering from intractable nausea and vomiting caused by chemotherapy. The federal drug agencies had placed all their faith in nabilone, an Eli Lilly drug that was being fast-tracked through FDA. It had shown great promise as an anti-emetic. But then research animals in long-term studies of the drug began to die. The federal government had no choice but to release synthetic delta-9 THC, now known as Marinol.The federal government did not originally intend for delta-9 THC to be used as a medicine. However, in the late 1970s, the medical marijuana movement exerted significant pressure on drug agencies to provide relief for cancer patients experiencing severe nausea and vomiting due to chemotherapy. The federal drug agencies had relied on nabilone, a drug developed by Eli Lilly, which was undergoing expedited approval by the FDA and showed promise as an anti-emetic. Unfortunately, during long-term studies, research animals began to die while on the drug. Consequently, the federal government had no choice but to release synthetic delta-9 THC, now known as Marinol.
The federal government never intended for delta-9 THC to be released as a medicine, but in the late 1970s, the medical marijuana movement placed immense pressure on drug agencies to help cancer patients who were suffering from intractable nausea and vomiting caused by chemotherapy. The federal drug agencies had placed all their faith in nabilone, an Eli Lilly drug that was being fast-tracked through FDA. It had shown great promise as an anti-emetic. But then research animals in long-term studies of the drug began to die. The federal government had no choice but to release synthetic delta-9 THC, now known as Marinol.The federal government did not originally intend for delta-9 THC to be used as a medicine. However, in the late 1970s, the medical marijuana movement exerted significant pressure on drug agencies to provide relief for cancer patients experiencing severe nausea and vomiting due to chemotherapy. The federal drug agencies had relied on nabilone, a drug developed by Eli Lilly, which was undergoing expedited approval by the FDA and showed promise as an anti-emetic. Unfortunately, during long-term studies, research animals began to die while on the drug. Consequently, the federal government had no choice but to release synthetic delta-9 THC, now known as Marinol.
The federal government never intended for delta-9 THC to be released as a medicine, but in the late 1970s, the medical marijuana movement placed immense pressure on drug agencies to help cancer patients who were suffering from intractable nausea and vomiting caused by chemotherapy. The federal drug agencies had placed all their faith in nabilone, an Eli Lilly drug that was being fast-tracked through FDA. It had shown great promise as an anti-emetic. But then research animals in long-term studies of the drug began to die. The federal government had no choice but to release synthetic delta-9 THC, now known as Marinol.The federal government did not originally intend for delta-9 THC to be used as a medicine. However, in the late 1970s, the medical marijuana movement exerted significant pressure on drug agencies to provide relief for cancer patients experiencing severe nausea and vomiting due to chemotherapy. The federal drug agencies had relied on nabilone, a drug developed by Eli Lilly, which was undergoing expedited approval by the FDA and showed promise as an anti-emetic. Unfortunately, during long-term studies, research animals began to die while on the drug. Consequently, the federal government had no choice but to release synthetic delta-9 THC, now known as Marinol.